Spatial Genomics and Transcriptomics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Jan 2024

Pages: 162

SKU: IRTNTR73547

Snapshot

Spatial Genomics and Transcriptomics Market 2024-2028

The global spatial genomics and transcriptomics market size is estimated to grow by USD 619.21 million, at a CAGR of 11.22% between 2023 and 2028.

Spatial genomics and transcriptomics play a crucial role in developing innovative therapeutic approaches, leveraging extensive and complex data generation. The growing adoption of these techniques is propelled by user-friendly analysis tools for drug discovery. These emerging fields enable scientists to capture gene expression information along with the spatial context of tissue samples, facilitating the profiling of clinical samples to map molecular tissue taxonomy and localize cell types, providing valuable insights into disease progression. Hence, the increase in the adoption of spatial genomics and transcriptomics in drug discovery and development will drive the growth of the market during the forecast period.

Technavio has segmented the market into Application, Product, and Geography

The application segment includes translation research, drug discovery, and development
The product segment includes consumables and instruments
The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Application, Product, and Geography Analysis

Application Analysis

Translation research

The market share growth by the translation research segment will be significant during the forecast period. Spatial genomics and transcriptomics revolutionize translational research by offering insights into tissue spatial organization. In cancer, they identify distinct tumor microenvironments, guiding personalized therapies. For neurological disorders, spatial transcriptomics illuminates brain gene expression, aiding targeted therapies. In infectious diseases, spatial genomics maps pathogen distribution, enhancing precision in treatment interventions.

Get a glance at the market contribution of various segments Download PDF Sample

The translation research segment was valued at USD 369.70 million in 2018. Moreover, spatial genomics and transcriptomics play a key role in immunotherapy research. By characterizing the spatial distribution of immune cells and their gene expression profiles within the tumor microenvironment, researchers can tailor immunotherapies to improve the immune response against cancer. Consequently, spatial genomics and transcriptomics in translational research have revolutionized the understanding of diseases by providing spatially resolved molecular information. Thus, such factors will drive the growth of the translational research segment of the market during the forecast period.

Product Analysis

Consumables

Spatial genomics and transcriptomics, cutting-edge technologies, study gene expression within tissue spatial organization. Crucial consumables include spatially barcoded slides or chips for gene expression patterns, integrating microfluidics. Transcriptomics employs spatially barcoded beads capturing RNA positions, enabling comprehensive spatial analysis of multiple genes. Consumables like primers and probes contribute to genetic material preparation, ensuring reliable, reproducible spatially resolved data and advancing understanding of biological tissue organization. Thus, such factors will drive the growth of the consumables segment of the market during the forecast period.

Instruments

Spatial genomics and transcriptomics rely on advanced instruments like sequencing platforms, microscopy, flow cytometry, and mass spectrometry for precise gene expression mapping in tissues. Key tools include spatial transcriptomics platforms with barcoded slides, RNA in-situ hybridization, and single-cell RNA sequencing. High-resolution microscopy captures detailed spatial information, while microarray-based and NGS platforms analyze transcript abundance. Emerging technologies, including spatially barcoded beads and droplet-based systems, enhance scalability and sensitivity, forming a sophisticated toolkit that aids researchers in unraveling spatial gene expression complexities for therapeutic advancements in drug discovery. Thus, such factors will drive the growth of the instruments segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American spatial genomics and transcriptomics market growth is fueled by numerous laboratories, research facilities, and pharmaceutical firms, particularly in the US and Canada. Thermo Fisher Scientific, among other market players, contributes to the region's market expansion through innovative technologies. The competitive US market sees vendors concentrating on proprietary advancements for applications like oncology and rare disease diagnosis. Targeting end-users like biopharmaceutical companies and research institutions, vendors aim to penetrate cancer-related translational and clinical research, presenting opportunities for revenue growth and expanded product applications in this dynamic research landscape. Hence, such factors are expected to drive market growth in this region during the forecast period.

Buy Full Report Now

Key Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

10X Genomics Inc.: The company offers spatial genomics and transcriptomics solutions such as Visium Spatial Gene Expression that allows researchers to map the activity of thousands of genes within intact tissue sections while preserving both their spatial context and morphology.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.

Key Drivers

Rising product launches and strategic alliances by companies are the key factors driving market growth. Market players are implementing various strategies, like new product launches, collaborations, and partnerships, to maintain and boost their position in the market. For Example, in April 2023, Bio-Techne Corporation entered into a partnership with Lunaphore Technologies SA to design and develop the world's first automated spatial omics multi-workflow. This system will be designed to provide complete flexibility in panel design.

Similarly, Illumina Inc. entered into a strategic research collaboration with AstraZeneca plc in October 2022 to accelerate drug target discovery by combining their strengths in Al-based genome interpretation and genomic analysis techniques with industry expertise. Thus, the increasing number of new product launches and strategic alliances by companies will drive the growth of the market during the forecast period.

Significant Trends

Increasing use of spatial omics for biomarker identification is the primary trend shaping market growth. Biomarkers play an important role in simplifying drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs. Additionally, biomarkers are widely used in diagnosing diseases like cancer, cardiovascular disease, and neurological disease. Also, aligning with market trends and analysis biomarkers has enabled scientists and medical researchers to get a better understanding and locate the target gene in the disease pathway and progression.

Furthermore, the drug discovery of new biomarkers in the diagnosis of various diseases, particularly cancer, has brought about revolutionary changes in medicine. In addition, continuous developments in sequencing technologies have increased the efficacy of biomarkers in disease detection and their utilization in disease diagnoses. Hence, spatial genomics and transcriptomics have the potential to aid in novel clinical-relevant biomarker discovery in the coming years; hence, the market in focus will grow significantly during the forecast period.

Major Challenges

The lack of a workforce with expertise in handling spatial genomics and transcriptomics is a challenge that affects market growth. Spatial genomics and transcriptomics need skilled professionals, like researchers, and laboratory technicians, who can conduct spatial genomics and transcriptomics. Their duties also include understanding the underlying genomic mechanisms and biological entities. Performing experiments for spatial genomics and transcriptomics is a labor-intensive process.

Furthermore, the lack of adequate knowledge, training, and courses on spatial genomics and transcriptomics available for the detection and staging of a disease is one of the prime factors limiting the number of students who opt to become laboratory technicians. Consequently, the lack of a skilled workforce is a restraining factor for the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. The market growth and forecasting focus on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Segment Overview

The market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends opportunities from 2018 to 2028.

Application Outlook
- Translation research
- Drug discovery and development

Product Outlook
- Consumables
- Instruments

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World (ROW)
  - Brazil
  - Argentina
  - Australia

Spatial Genomics and Transcriptomics Market Scope
Report Coverage	Details
Page number	162
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 11.22%
Market Growth 2024-2028	USD 619.21 million
Market structure	Fragmented
YoY growth 2023-2024(%)	9.31
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	10X Genomics Inc., Akoya Biosciences Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., RareCyte Inc., Rebus Biosystems Inc., Resolve BioSciences GmbH, S2 Genomics Inc., Seven Bridges Genomics Inc., Singular Genomics System Inc., Ultivue Inc., Veranome Biosystems LLC, Vizgen Corp., and PerkinElmer Inc
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market forecast between 2024 and 2028
Precise estimation of the size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global spatial genomics and transcriptomics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global spatial genomics and transcriptomics market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Translation research - Market size and forecast 2023-2028
- Exhibit 34: Chart on Translation research - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Translation research - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Translation research - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Translation research - Year-over-year growth 2023-2028 (%)

6.4 Drug discovery and development - Market size and forecast 2023-2028
- Exhibit 38: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Product - Market share 2023-2028 (%)

7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product

7.3 Consumables - Market size and forecast 2023-2028
- Exhibit 48: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Consumables - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Consumables - Year-over-year growth 2023-2028 (%)

7.4 Instruments - Market size and forecast 2023-2028
- Exhibit 52: Chart on Instruments - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Instruments - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Instruments - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Instruments - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Product
- Exhibit 56: Market opportunity by Product ($ million)
- Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 10X Genomics Inc.
- Exhibit 107: 10X Genomics Inc. - Overview
- Exhibit 108: 10X Genomics Inc. - Product / Service
- Exhibit 109: 10X Genomics Inc. - Key offerings

12.4 Akoya Biosciences Inc.
- Exhibit 110: Akoya Biosciences Inc. - Overview
- Exhibit 111: Akoya Biosciences Inc. - Product / Service
- Exhibit 112: Akoya Biosciences Inc. - Key offerings

12.5 Bio Rad Laboratories Inc.
- Exhibit 113: Bio Rad Laboratories Inc. - Overview
- Exhibit 114: Bio Rad Laboratories Inc. - Business segments
- Exhibit 115: Bio Rad Laboratories Inc. - Key news
- Exhibit 116: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 117: Bio Rad Laboratories Inc. - Segment focus

12.6 Bio Techne Corp.
- Exhibit 118: Bio Techne Corp. - Overview
- Exhibit 119: Bio Techne Corp. - Business segments
- Exhibit 120: Bio Techne Corp. - Key offerings
- Exhibit 121: Bio Techne Corp. - Segment focus

12.7 Fulgent Genetics Inc.
- Exhibit 122: Fulgent Genetics Inc. - Overview
- Exhibit 123: Fulgent Genetics Inc. - Product / Service
- Exhibit 124: Fulgent Genetics Inc. - Key offerings

12.8 Illumina Inc.
- Exhibit 125: Illumina Inc. - Overview
- Exhibit 126: Illumina Inc. - Business segments
- Exhibit 127: Illumina Inc. - Key news
- Exhibit 128: Illumina Inc. - Key offerings
- Exhibit 129: Illumina Inc. - Segment focus

12.9 Lunaphore Technologies SA
- Exhibit 130: Lunaphore Technologies SA - Overview
- Exhibit 131: Lunaphore Technologies SA - Product / Service
- Exhibit 132: Lunaphore Technologies SA - Key offerings

12.10 NanoString Technologies Inc.
- Exhibit 133: NanoString Technologies Inc. - Overview
- Exhibit 134: NanoString Technologies Inc. - Product / Service
- Exhibit 135: NanoString Technologies Inc. - Key offerings

12.11 PerkinElmer Inc
- Exhibit 136: PerkinElmer Inc - Overview
- Exhibit 137: PerkinElmer Inc - Business segments
- Exhibit 138: PerkinElmer Inc - Key news
- Exhibit 139: PerkinElmer Inc - Key offerings
- Exhibit 140: PerkinElmer Inc - Segment focus

12.12 RareCyte Inc.
- Exhibit 141: RareCyte Inc. - Overview
- Exhibit 142: RareCyte Inc. - Product / Service
- Exhibit 143: RareCyte Inc. - Key offerings

12.13 Rebus Biosystems Inc.
- Exhibit 144: Rebus Biosystems Inc. - Overview
- Exhibit 145: Rebus Biosystems Inc. - Product / Service
- Exhibit 146: Rebus Biosystems Inc. - Key offerings

12.14 Resolve BioSciences GmbH
- Exhibit 147: Resolve BioSciences GmbH - Overview
- Exhibit 148: Resolve BioSciences GmbH - Product / Service
- Exhibit 149: Resolve BioSciences GmbH - Key offerings

12.15 S2 Genomics Inc.
- Exhibit 150: S2 Genomics Inc. - Overview
- Exhibit 151: S2 Genomics Inc. - Product / Service
- Exhibit 152: S2 Genomics Inc. - Key offerings

12.16 Seven Bridges Genomics Inc.
- Exhibit 153: Seven Bridges Genomics Inc. - Overview
- Exhibit 154: Seven Bridges Genomics Inc. - Product / Service
- Exhibit 155: Seven Bridges Genomics Inc. - Key offerings

12.17 Veranome Biosystems LLC
- Exhibit 156: Veranome Biosystems LLC - Overview
- Exhibit 157: Veranome Biosystems LLC - Product / Service
- Exhibit 158: Veranome Biosystems LLC - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 159: Inclusions checklist
- Exhibit 160: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 161: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 162: Research methodology
- Exhibit 163: Validation techniques employed for market sizing
- Exhibit 164: Information sources

13.5 List of abbreviations
- Exhibit 165: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

spatial genomics and transcriptomics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis